Skip to content

Ovarian Cancer Health Center

Test May Help Predict Survival From Ovarian Cancer

Method was used to count special type of immune cells in tumors from 30 women in study
Font Size
A
A
A

WebMD News from HealthDay

By Steven Reinberg

HealthDay Reporter

WEDNESDAY, Dec. 4 (HealthDay News) -- By counting the number of cancer-fighting immune cells inside tumors, scientists say they may have found a way to predict survival from ovarian cancer.

The researchers developed an experimental method to count these cells, called tumor-infiltrating T lymphocytes (TILs), in women with early stage and advanced ovarian cancer.

"We have developed a standardizable method that should one day be available in the clinic to better inform physicians on the best course of cancer therapy, therefore improving treatment and patient survival," said lead researcher Jason Bielas, at the Fred Hutchinson Cancer Research Center, in Seattle.

The test may have broader implications beyond ovarian cancer and be useful with other types of cancer, the study authors suggested.

In their current work with ovarian cancer patients, the researchers "demonstrated that this method can be used to diagnose T-cells quickly and effectively from a blood sample," said Bielas, an associate member in human biology and public health sciences.

The report was published online Dec. 4 in Science Translational Medicine.

The researchers developed the test to count TILs, identify their frequency and develop a system to determine their ability to clone themselves. This is a way of measuring the tumor's population of immune T-cells.

The test works by collecting genetic information of proteins only found in these cells.

"T-cell clones have unique DNA sequences that are [comparable] to product barcodes on items at the grocery store. Our technology is comparable to a barcode scanner," Bielas said.

The technique, called QuanTILfy, was tested on tumor samples from 30 women with ovarian cancer whose survival ranged from one month to about 10 years.

Bielas and colleagues looked at the number of TILs in the tumors, comparing those numbers to the women's survival.

The researchers found that higher TIL levels were linked with better survival. For example, the percent of TILs was about three times higher in women who survived more than five years than in those who survived less than two years.

"We are hoping to investigate whether this is a general phenomena of all cancers," Bielas said. "There is good evidence now that the same associations can be made for melanoma and colorectal cancer."

Today on WebMD

Ovarian cancer illustration
What are the symptoms?
doctory with x-ray
Get to know the Symptoms.
 
cancer cell
HPV is the top cause. Find out more.
Lung cancer xray
See it in pictures, plus read the facts.
 
Integrative Medicine Cancer Quiz
QUIZ
Lifestyle Tips for Depression Slideshow
SLIDESHOW
 
Screening Tests for Women
Slideshow
Graphic of ovaries within reproductive system
VIDEO
 
Ovarian Cancer Marker
VIDEO
Pets Improve Your Health
SLIDESHOW
 
Vitamin D
SLIDESHOW
Healthy meal with salmon
Article